Cedars-Sinai Cancer has launched a Clinical and Regulatory Sciences Graduate Certificate Program, which begins in the fall of 2022.
Jane Figueiredo was appointed co-leader of the Cancer Prevention and Control Program at Cedars-Sinai Cancer Center.
Cedars-Sinai Cancer Center launches clinical and regulatory sciences graduate certificate program
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
A new donor-funded project is offering free assistance to newly-diagnosed cancer patients across Los Angeles County to help them navigate the appointments, tests, options, and challenges that come with a life-altering diagnosis.
Indrin Chetty was selected as the new vice chair of research and director of the medical physics division in the Department of Radiation Oncology at Cedars-Sinai Cancer.
Leo Mascarenhas was named director of Pediatric Hematology & Oncology at Cedars-Sinai Guerin Children’s and medical director of the Sarcoma Program at Cedars-Sinai Cancer Center.
The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.
